Oral Galactose Provides a Different Approach to Incretin-Based Therapy of Alzheimer's Disease
Journal of Neurology & Neuromedicine
doi 10.29245/2572.942x/2018/4.1204
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2018
Authors
Publisher
Sciaccess Publishers LLC